Photo of Eric B. Suhler, M.D., M.P.H.

Eric B. Suhler M.D., M.P.H.

After completing his training in ophthalmology at the Casey Eye Institute in 2000, Dr. Suhler received an additional two years of training in uveitis clinical care and research at the National Eye Institute of the National Institutes of Health in Bethesda, Maryland from 2000 to 2002, and completed a Masters in Public Health from OHSU in 2007. 

He is co-director of the OHSU Uveitis Clinic, where he sees patients on referral from eye care providers throughout the Pacific Northwest. He is active in clinical research and clinical trials utilizing cutting edge immunotherapeutic drugs for the treatment of ocular inflammatory diseases and has regularly presented the results of these trials at national and international research meetings. Dr. Suhler also directs the Casey Uveitis Fellowship.

Dr. Suhler is also chief of ophthalmology at the Portland Veterans Administration Medical Center. He received his undergraduate education at Southern Methodist University in Dallas, Texas, and attended medical school at the University of Texas Southwestern Medical Center in Dallas.

Read more

Education

  • M.D., University of Texas, Southwestern Medical Center, Dallas Texas 1995
  • M.P.H., Oregon Health and Science University, Portland Oregon 2007
  • Residency:

    • Ophthalmology: OHSU, 2000
  • Fellowship:

    • Uveitis and clinical ocular immunology: NIH, 2002
  • Certifications:

    • Ophthalmology

Publications

  • "Risk of hypotony in noninfectious uveitis" Ophthalmology November 2012
  • "Peripheral vascular leakage in uveitis" Ophthalmology June 1 2015
  • "In reply [2]" JAMA Ophthalmology  2006
  • "Management of fluocinolone implant dissociation during implant exchange" JAMA Ophthalmology September 2009
  • "A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease" Ocular Immunology and Inflammation March 2007
  • "Hepatitis B vaccine and uveitis" Cutaneous and Ocular Toxicology March 2010
  • "Interferon alpha 2b in the treatment of uveitic cystoid macular edema" Ocular Immunology and Inflammation April 2012
  • "Mycophenolate mofetil for the treatment of scleritis" Ophthalmology September 1 2003
  • "In reply [2]" JAMA Ophthalmology August 2006
  • "Possible association between scleritis and lymphoma [18]" British Journal of Ophthalmology December 2007
  • "Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort." Retina February 2009
  • "Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis" Critical Care Medicine April 1997
  • "Cytomegalovirus retinitis in the absence of AIDS" Canadian Journal of Ophthalmology  2013
  • "Biologic therapies for inflammatory eye disease" Clinical and Experimental Ophthalmology May 2006
  • "Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists" Ocular Immunology and Inflammation February 1 2015
  • "Characteristics and visual outcome of patients with retinal vasculitis" JAMA Ophthalmology October 2012
  • "Factors predictive of remission of new-onset anterior uveitis" Ophthalmology March 2014
  • "Toxoplasmosis retinochoroiditis and elevated intraocular pressure" Journal of Glaucoma February 2005
  • "A standardized grading system for scleritis" Ophthalmology April 2011
  • "Endogenous Streptococcus agalactiae (Group B Streptococcus) endophthalmitis as a presenting sign of precursor T-cell lymphoblastic leukemia" JAMA Ophthalmology March 2010
  • "Humanized anti-interleukin-2 (IL-2) receptor alpha therapy" Journal of Autoimmunity November 2003
  • "Infliximab therapy for refractory uveitis" JAMA Ophthalmology June 2009
  • "Rituximab for treatment of ocular inflammatory disease" British Journal of Ophthalmology April 2009
  • "Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis" Journal of Ophthalmic Inflammation and Infection December 2012
  • "Mycobacterial diseases and antitumour necrosis factor therapy in USA" Annals of the Rheumatic Diseases January 2013
  • "Biologic therapy for posterior uveitis and panuveitis" Retina Today April 2012
  • "Ocular Inflammation in Behçet Disease" American Journal of Ophthalmology December 2008
  • "Rituximab therapy for refractory orbital inflammation results of a phase 1/2, dose-ranging, randomized clinical trial" JAMA Ophthalmology  2014
  • "Cyclosporine for Ocular Inflammatory Diseases" Ophthalmology March 2010
  • "Azathioprine for Ocular Inflammatory Diseases" American Journal of Ophthalmology October 2009

Additional information

Edit profile